91

020 7713 0990
020 7713 0990
Diagnosed cases of B-cell non-Hodgkin’s lymphoma (NHL) are set to increase by 15% in the next decade, according to a new analysis. Analysts GlobalData say the complexity of the disease mean health services need a “nuanced” understanding of its sub...
4 months ago
An “armoured” version of CAR-T treatment has shown promise against treatment-resistant B-cell lymphoma, researchers have reported. More than half of the 21 patients in a phase I trial experienced complete remissions, the researchers at the Univers...
4 months ago